1. Accelerated production of human epithelial organoids in a miniaturized spinning bioreactor
- Author
-
Ye, Shicheng, Marsee, Ary, van Tienderen, Gilles S, Rezaeimoghaddam, Mohammad, Sheikh, Hafsah, Samsom, Roos-Anne, de Koning, Eelco J P, Fuchs, Sabine, Verstegen, Monique M A, van der Laan, Luc J W, van de Vosse, Frans, Malda, Jos, Ito, Keita, Spee, Bart, Schneeberger, Kerstin, Ye, Shicheng, Marsee, Ary, van Tienderen, Gilles S, Rezaeimoghaddam, Mohammad, Sheikh, Hafsah, Samsom, Roos-Anne, de Koning, Eelco J P, Fuchs, Sabine, Verstegen, Monique M A, van der Laan, Luc J W, van de Vosse, Frans, Malda, Jos, Ito, Keita, Spee, Bart, and Schneeberger, Kerstin
- Abstract
Conventional static culture of organoids necessitates weekly manual passaging and results in nonhomogeneous exposure of organoids to nutrients, oxygen, and toxic metabolites. Here, we developed a miniaturized spinning bioreactor, RPMotion, specifically optimized for accelerated and cost-effective culture of epithelial organoids under homogeneous conditions. We established tissue-specific RPMotion settings and standard operating protocols for the expansion of human epithelial organoids derived from the liver, intestine, and pancreas. All organoid types proliferated faster in the bioreactor (5.2-fold, 3-fold, and 4-fold, respectively) compared to static culture while keeping their organ-specific phenotypes. We confirmed that the bioreactor is suitable for organoid establishment directly from biopsies and for long-term expansion of liver organoids. Furthermore, we showed that after accelerated expansion, liver organoids can be differentiated into hepatocyte-like cells in the RPMotion bioreactor. In conclusion, this miniaturized bioreactor enables work-, time-, and cost-efficient organoid culture, holding great promise for organoid-based fundamental and translational research and development.
- Published
- 2024